Mountain View, CA, 25 July 2006
IMPAC Medical Systems, Inc. (IMPAC), an Elekta Company and a
leading provider of information technology solutions for
oncology care, announces that since May 2006 The University of
Texas M. D. Anderson Cancer Center has been in clinical use with
IMPAC's treatment management solution to manage delivery and
chart radiation therapy treatments at its new proton therapy
center.
“The clinical implementation of EMR support for proton therapy
represents years of collaborative design and development between
M. D. Anderson Cancer Center and IMPAC,” stated Annette Coleman,
IMPAC’s product manager for multi-modality, image enabled
charting. Coleman added that while the project focused primarily
on EMR support for proton therapy, customers using more
conventional treatment methods will benefit from the work done
on this project. “Many new and exciting features developed for
proton therapy will soon be incorporated into the conventional
treatment environment within MOSAIQ™, including fundamental
enhancements and added efficiencies to the treatment delivery
process.”
“The proton therapy center was among the many innovative patient
care projects undertaken by M. D. Anderson Cancer Center,
resulting from the sum total of the hard work of a
multi-disciplinary team including radiation oncologists,
physicists, information services professionals and senior
leadership,” stated James D. Cox, MD, Professor and Head,
Division of Radiation Oncology. “Moreover, the shared vision
and effort of a group of vendors including IMPAC made the
process manageable and the outcome a reality. IMPAC integrated
proton support into our existing IT implementation, allowing us
to extend our current chartless radiation therapy environment to
the new proton center.”
“IMPAC continues its mission to provide the best oncology
information management system to support any combination of
treatment planning and delivery equipment our customers may
choose,” stated Jay Hoey, President and CEO of IMPAC. “The
development efforts devoted to the proton center further
demonstrate our dedication to providing leading-edge clinical
capabilities in multi-manufacturer environments, empowering
customers to pursue best-of-breed solutions. Our worldwide
installed base of oncology EMRs, which integrates with planning
systems and treatment devices from multiple manufacturers,
demonstrates how we leverage our experience to provide
comprehensive management of advanced radiation therapy
treatments.”
The multi-vendor team that collaborated with IMPAC to meet M. D.
Anderson’s specific clinical requirements included Hitachi, Ltd.
and Varian Medical Systems.
For more information, please contact:
Lorna Murdock,
Marketing
Communications Manager
IMPAC Medical Systems, Inc.
Tel: +1 650-623-8937, e-mail:
lmurdock@impac.com
Product
Inquiries:
Adam Earwicker
IMPAC Medical Systems, Inc.
Tel: 760-743-2899,
e-mail: aearwicker@impac.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail:
peter.ejemyr@elekta.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., an Elekta company, provides
healthcare information technology (IT) solutions that streamline
clinical and business operations across the spectrum of cancer
care. IMPAC’s open integration to multiple healthcare data and
imaging systems offers oncology-specific patient charting and
practice management, as well as best-of-breed systems for
anatomic pathology, clinical laboratory, and cancer registry.
With products that are used in association with diagnosis and
treatment environments through long-term follow-up, IMPAC
provides a comprehensive oncology management solution that helps
improve overall communication, process efficiency, and the
quality of patient care. For more information about IMPAC
products and services, please call 888-GO-IMPAC or visit
www.impac.com.
About
Elekta
Elekta is an
international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and
services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for
non-invasive treatment of brain disorders and Elekta Synergy®
for image guided radiation therapy (IGRT). Following the
acquisition of IMPAC Medical Systems Inc. in April 2005, the
Elekta Group is the world’s largest supplier of oncology
software. Elekta’s systems and solutions are used at over 3,000
hospitals around the world to treat cancer and manage clinical
operations as well as to diagnose and treat brain disorders,
including tumors, vascular malformations and functional
disorders. With approx. 1,850 employees, Elekta’s corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Stockholm Stock Exchange under the ticker EKTAb.
For more information about Elekta, please visit
www.elekta.com.
|
